The first patient completed a course of treatment with a domestic mRNA vaccine against melanoma
Quick Look
- The course of treatment for the first patient who received the domestic mRNA vaccine “Neoonkovak” for the treatment of skin melanoma was completed with good results.
- The second patient has already received a second injection of the vaccine, and several more patients are being prepared.
- This was announced by the chief oncologist of the Ministry of Health of the Russian Federation Andrei Kaprin.
AI-generated summary
Why It Matters
In April, at the National Medical Research Center of Radiology of the Russian Ministry of Health, a patient with skin melanoma was given the personalized antitumor mRNA vaccine “Neoonkovak” for the first time.
The course of treatment for the first patient who received a domestic mRNA vaccine for the treatment of skin melanoma was completed with good results.
The second patient has already received a second injection of the vaccine, and several more patients are being prepared.
In April, at the National Medical Research Center of Radiology of the Russian Ministry of Health, a patient with skin melanoma was given the personalized antitumor mRNA vaccine “Neoonkovak” for the first time.
MOSCOW, September 15 - RIA Novosti. The course of treatment for the first patient who received a domestic mRNA vaccine for the treatment of skin melanoma ended with a good result, said the chief oncologist of the Ministry of Health of the Russian Federation, General Director of the National Medical Research Center of Radiology of the Ministry of Health of Russia, Academician of the Russian Academy of Sciences Andrey Kaprin.
“We finished one patient (injecting mRNA - ed.) with a good result about three weeks ago. Now the second one is getting his second injection. Several more patients are being prepared,” Kaprin told Vesti IS.
Earlier, Denis Logunov, director of the National Research Center for Epidemiology and Microbiology named after honorary academician N. F. Gamaleya of the Ministry of Health of the Russian Federation, said that two patients have already received the Russian vaccine against skin cancer, and another 36 people will receive it this year.
What to Watch
AI outlook — possibilities, not facts
Another 36 patients will receive the Russian vaccine against skin cancer this year
Very likely · Within months
Open Questions
- What percentage of effectiveness did the vaccine show in the first patient?
- When is it planned to complete recruitment of all patients for clinical trials?
- What side effects were recorded during treatment?
